The idea is that most prostate cancers grow so slowly that they won't cause symptoms or shorten your lifespan, even if they’re left untreated. Prostate cancer treatments, on the other hand, can cause ...

Although about 1 in 8 men in the U.S. will be diagnosed with prostate cancer during their lifetime, only about 1 in 44 will die from it. Most men diagnosed with prostate cancer die from other causes, ...

Prostate cancer comes in all kinds of varieties, from serious and life-threatening cases all the way to the more common, nonaggressive forms that are typically age related. The disease tends to occur ...

Patients with favorable-risk prostate cancer “should be aware that they don't need treatment right away,” one expert said. Active surveillance has been shown to be an effective management strategy for ...

Please provide your email address to receive an email when new articles are posted on . From 2010 to 2018, rates of active surveillance/watchful waiting in the U.S. increased from 16.4% to 59.9% for ...

Read more about how low testosterone levels are linked to ‘extreme’ disease progression in patients with prostate cancer ...

Male patient talking to doctor. Data suggest that 125 men active surveillance would need to receive initial treatment to prevent 1 prostate cancer death at 10 years. Prostate cancer-specific survival ...

Overtreatment of men with prostate cancer and limited life expectancy (LE) has persisted in the era of active surveillance and worsened in some instances, according to a new study. “Overtreatment of ...

At 25 years, the prostate cancer-specific survival rate was 94% among men with screen-detected prostate cancer who chose primary active surveillance – but prostate cancer progression rates are high.

Please provide your email address to receive an email when new articles are posted on . “Although academic series have demonstrated the safety and appropriateness of active surveillance for many years ...

Jinping Xu receives funding from the American Cancer Society and the U.S. Department of Defense. Although about 1 in 8 men in the U.S. will be diagnosed with prostate cancer during their lifetime, ...

Half of men with low-risk prostate cancer remained free from progression or treatment 10 years after diagnosis when followed in a protocol-directed active surveillance program. At 10 years, 43% of ...